These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35694127)

  • 1. Regulative role of the CXCL13-CXCR5 axis in the tumor microenvironment.
    Tan P; Shi M; Lai L; Tang Z; Xie N; Xu H; Wei Q; Zhang X; Yang L; Wu L
    Precis Clin Med; 2018 Jun; 1(1):49-56. PubMed ID: 35694127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13 Signaling in the Tumor Microenvironment.
    Hussain M; Liu J; Wang GZ; Zhou GB
    Adv Exp Med Biol; 2021; 1302():71-90. PubMed ID: 34286442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL13/CXCR5 signaling axis in cancer.
    Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J
    Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
    Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities.
    Gao SH; Liu SZ; Wang GZ; Zhou GB
    Life (Basel); 2021 Nov; 11(12):. PubMed ID: 34947813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.
    Ohandjo AQ; Liu Z; Dammer EB; Dill CD; Griffen TL; Carey KM; Hinton DE; Meller R; Lillard JW
    Sci Rep; 2019 Oct; 9(1):14963. PubMed ID: 31628349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and application of chemokine CXCL13 in central nervous system lymphoma.
    Li C; Zhang L; Jin Q; Jiang H; Wu C
    Ann Hematol; 2023 Nov; ():. PubMed ID: 38010409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond.
    Kazanietz MG; Durando M; Cooke M
    Front Endocrinol (Lausanne); 2019; 10():471. PubMed ID: 31354634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway.
    Zhu Z; Zhang X; Guo H; Fu L; Pan G; Sun Y
    Mol Cell Biochem; 2015 Feb; 400(1-2):287-95. PubMed ID: 25476740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
    Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.
    Pimenta EM; De S; Weiss R; Feng D; Hall K; Kilic S; Bhanot G; Ganesan S; Ran S; Barnes BJ
    Immunol Cell Biol; 2015; 93(5):486-99. PubMed ID: 25533286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.
    Hsieh CH; Jian CZ; Lin LI; Low GS; Ou PY; Hsu C; Ou DL
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the Role of the CXCL13/CXCR5-Associated Immune Axis in Melanoma: Potential Implications for Anti-PD-1-Related Biomarker Research.
    Hoellwerth M; Koelblinger P; Lang R; Harrer A
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
    Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
    J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica.
    Graver JC; Abdulahad W; van der Geest KSM; Heeringa P; Boots AMH; Brouwer E; Sandovici M
    J Autoimmun; 2021 Sep; 123():102684. PubMed ID: 34237649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection.
    Steinmetz OM; Panzer U; Kneissler U; Harendza S; Lipp M; Helmchen U; Stahl RA
    Kidney Int; 2005 Apr; 67(4):1616-21. PubMed ID: 15780119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome.
    Zhao J; Chen S; Yang C; Zhou M; Yang T; Sun B; Zhu J; Zhang H; Lu Q; Li L; Yang Z; Song B; Shen W; Yi S; Dai S
    Biochem Pharmacol; 2022 Jun; 200():115047. PubMed ID: 35452631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases.
    Aust G; Sittig D; Becherer L; Anderegg U; Schütz A; Lamesch P; Schmücking E
    Eur J Endocrinol; 2004 Feb; 150(2):225-34. PubMed ID: 14763921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR5/CXCL13 interaction is important for double-negative regulatory T cell homing to cardiac allografts.
    Lee BP; Chen W; Shi H; Der SD; Förster R; Zhang L
    J Immunol; 2006 May; 176(9):5276-83. PubMed ID: 16621993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.